Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats Raul C Maranhão,1,2 Maria C Guido,1 Aline D de Lima,1 Elaine R Tavares,1 Alyne F Marques,1 Marcelo D Tavares de Melo,3 Jose C Nicolau,3 Vera MC Salemi,3 Roberto Kalil-Filho3 1Laboratory of Metabolism and Lipids, 2Faculty. Moved Permanently. The document has moved here. Summary. Acute myocardial infarction is found among people who take Methotrexate, especially for people who are female, 60+ old , have been taking the drug for 10+ years, also take medication Folic Acid, and have High blood pressure. The occurrence of a myocardial infarction is reported after chemotherapy containing etoposide, in a man with no risk factors for coronary heart disease. Possible causal mechanisms are discussed. We conducted a randomized, double-blind trial of low-dose methotrexate (at a target dose of 15 to 20 mg weekly) or matching placebo in 4786 patients with previous myocardial infarction or. Myocardial infarction is found among people who take Methotrexate, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Humira, and have High blood pressure. Introduction. Patients with rheumatoid arthritis (RA) are known to have an increased risk of premature mortality compared with the general population, primarily due to an increased incidence of cardiovascular disease (CVD), particularly coronary artery disease [Aviña-Zubieta et al. 2008]. Purpose:Methotrexate is an anti-inflammatory drug that has been shown to have anti-ischemic effects. Our aim was to evaluate if methotrexate could reduce infarct size in patients with ST-segment elevation myocardial infarction (STEMI).Methods:We randomly assigned patients with STEMI to receive either methotrexate or placebo. Primary outcome was. Infarction Myocardial Infarction ST Elevation Myocardial Infarction Ischemia Pathologic Processes Necrosis Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases Methotrexate Riboflavin Abortifacient Agents, Nonsteroidal Abortifacient Agents Reproductive Control Agents Introduction: Acute myocardial infarction provokes inflammatory activation. Methotrexate is one drug that has been shown to have anti-ischemic effects in experimental studies. Hypothesis: Methotrexate could reduce inflammation and the ischemia area in acute myocardial infarction Methods: We randomly.